BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11051842)

  • 21. PTEN.
    Stokoe D
    Curr Biol; 2001 Jul; 11(13):R502. PubMed ID: 11470419
    [No Abstract]   [Full Text] [Related]  

  • 22. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural assets of a tumor suppressor.
    Tonks NK; Myers MP
    Science; 1999 Dec; 286(5447):2096-7. PubMed ID: 10617421
    [No Abstract]   [Full Text] [Related]  

  • 24. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
    Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
    Davies MA; Lu Y; Sano T; Fang X; Tang P; LaPushin R; Koul D; Bookstein R; Stokoe D; Yung WK; Mills GB; Steck PA
    Cancer Res; 1998 Dec; 58(23):5285-90. PubMed ID: 9850049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells.
    Zhao H; Dupont J; Yakar S; Karas M; LeRoith D
    Oncogene; 2004 Jan; 23(3):786-94. PubMed ID: 14737113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTEN gene and integrin signaling in cancer.
    Tamura M; Gu J; Tran H; Yamada KM
    J Natl Cancer Inst; 1999 Nov; 91(21):1820-8. PubMed ID: 10547389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the PTEN phosphatase.
    Gericke A; Munson M; Ross AH
    Gene; 2006 Jun; 374():1-9. PubMed ID: 16675164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo.
    Ge NL; Rudikoff S
    Oncogene; 2000 Aug; 19(36):4091-5. PubMed ID: 10962569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. I-proteins - a proposed switch in myotubularin function.
    Clague MJ; Dove SK; Barr FA
    Trends Biochem Sci; 2004 Feb; 29(2):58-61. PubMed ID: 15102431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity.
    Hlobilkova A; Guldberg P; Thullberg M; Zeuthen J; Lukas J; Bartek J
    Exp Cell Res; 2000 May; 256(2):571-7. PubMed ID: 10772829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells.
    Lu Y; Lin YZ; LaPushin R; Cuevas B; Fang X; Yu SX; Davies MA; Khan H; Furui T; Mao M; Zinner R; Hung MC; Steck P; Siminovitch K; Mills GB
    Oncogene; 1999 Nov; 18(50):7034-45. PubMed ID: 10597304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
    Yamada KM; Araki M
    J Cell Sci; 2001 Jul; 114(Pt 13):2375-82. PubMed ID: 11559746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The multiple roles of PTEN in tumor suppression.
    Di Cristofano A; Pandolfi PP
    Cell; 2000 Feb; 100(4):387-90. PubMed ID: 10693755
    [No Abstract]   [Full Text] [Related]  

  • 35. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.
    Han SY; Kato H; Kato S; Suzuki T; Shibata H; Ishii S; Shiiba K; Matsuno S; Kanamaru R; Ishioka C
    Cancer Res; 2000 Jun; 60(12):3147-51. PubMed ID: 10866302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTEN: sometimes taking it off can be better than putting it on.
    Myers MP; Tonks NK
    Am J Hum Genet; 1997 Dec; 61(6):1234-8. PubMed ID: 9399917
    [No Abstract]   [Full Text] [Related]  

  • 37. The expanding role of PTEN in neoplasia: a molecule for all seasons? Commentary re: M. A. Davies, et al., Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clin. Cancer Res., 8: 1904-1914, 2002.
    Fernandez M; Eng C
    Clin Cancer Res; 2002 Jun; 8(6):1695-8. PubMed ID: 12060605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of the PTEN/MMAC1 gene in 136 breast cancer families.
    Chen J; Lindblom P; Lindblom A
    Hum Genet; 1998 Jan; 102(1):124-5. PubMed ID: 9490290
    [No Abstract]   [Full Text] [Related]  

  • 39. PTEN: a tumour suppressor that functions as a phospholipid phosphatase.
    Maehama T; Dixon JE
    Trends Cell Biol; 1999 Apr; 9(4):125-8. PubMed ID: 10203785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTEN, a unique tumor suppressor gene.
    Dahia PL
    Endocr Relat Cancer; 2000 Jun; 7(2):115-29. PubMed ID: 10903528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.